News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News November 14, 2025
Gibson Dunn Advising Merck on $9.2 Billion Acquisition of Cidara Therapeutics
Gibson Dunn is advising Merck on its $9.2 billion acquisition of Cidara Therapeutics, Inc., a biotechnology company developing drug-Fc conjugate (DFC) therapeutics
Firm News October 6, 2025
Gibson Dunn Represented Nuveen in Acquisition of Majority Interest in Ally Energy Solutions
Gibson Dunn advised Nuveen, a global investment manager, on its acquisition of a majority interest in Ally Energy Solutions, a comprehensive energy solutions provider.
Accolades October 3, 2025
Gibson Dunn Earns Multiple Recognitions in LMG Life Sciences 2025
The 2025 edition of LMG Life Sciences recognized Gibson Dunn for excellence in the following six practice areas
Client Alert April 16, 2025
Top Environmental, Health & Safety Issues to Think About in M&A Deals
An overview of environmental, health, and safety (EH&S) considerations in M&A transactions, which can impact risk allocation, valuation and the ability to operate after closing.
Accolades January 10, 2025
Lawdragon Names 21 Partners Among its 500 Leading Lawyers in America 2025
Lawdragon named 21 partners to its 500 Leading Lawyers in America 2025, a guide to the nation’s top lawyers.
Accolades October 18, 2024
Lawdragon Names 45 Partners Among its 500 Leading Dealmakers in America 2025
Lawdragon named 45 partners to its 500 Leading Dealmakers in America 2025, which honors “the eminents of M&A, the power players of private equity, the consiglieres of capital markets.”
Client Alert October 16, 2024
Top International Trade Issues to Think About in M&A Deals
An overview of International Trade considerations that most frequently impact deal timing, valuation, and ability to operate after closing.
Accolades October 8, 2024
LMG Life Sciences 2024 Recognizes Gibson Dunn in Six Practices and Names 14 Lawyers Stars
The 2024 edition of LMG Life Sciences highlighted six Gibson Dunn practices – Antitrust, Corporate, General Patent Litigation, Hatch-Waxman Patent Litigation (Branded), Mergers and Acquisitions, and White-Collar/Government Investigations – in the area of Life Sciences.